Single dose azithromycin

Details Single dose azithromycin Single dose azithromycin

2006-06-27

2006-06-27

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

07067493

ABSTRACT:
The present invention relates to a method of treating infections in humans by administering a single dose of azithromycin.

REFERENCES:
patent: 4328334 (1982-05-01), Kobrehel et al.
patent: 4474768 (1984-10-01), Bright
patent: 4517359 (1985-05-01), Kobrehel et al.
patent: 4963531 (1990-10-01), Remington
patent: 5498699 (1996-03-01), Djokic et al.
patent: 5605889 (1997-02-01), Curatolo et al.
patent: 5633006 (1997-05-01), Catania et al.
patent: 5686587 (1997-11-01), Yang
patent: 6068859 (2000-05-01), Curatolo et al.
patent: 6110965 (2000-08-01), Lazarevski et al.
patent: 6268489 (2001-07-01), Allen et al.
patent: 6569443 (2003-05-01), Dawson et al.
patent: 2004/0053264 (2004-03-01), Park
Block et al., “Single Dose Azithromycin (30 mg/kg) in Acute Otitis Media”, 38th Annual Meeting of the Infectious Disease Society of America, New Orleans, La., Sep. 7-10, 2000.
Schonwald, S., et al., Infection, Germany, vol. 27, No. 3, May 1999, pp. 198-202 XP008018295.
Amsden, G.W., et al., The J. of Antimicrobial Chemotherapy, 47(1), pp. 61-66 (2001) XP001159703.
Block, S., et al., 38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA, Sep. 7-10, 2000, Single-Sose Azithromycin (30mg/kg) in Acute Otitis Media, Abstract 174.
Muller O., The J. of Antimicrobial Chemotherapy, England, Jun. 1993, vol. 31, suppl. E, Jun. 1993, pp. 137-146 XP008018300.
Nightingale C.H., et al., J. of Infectious Disease Pharmacotherapy 1999, vol. 4, No. 1, pp. 17-24 XP008018297.
Aoki N., Japanese Journal of Chemotherapy 1995, Japan, vol. 43, No. Suppl 6, pp. 234-238 XP008018296.
Morris, D.L., et al., vol. 10, No. 10., Oct. 1991, pp. 859-861, European J. of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, Germany XP008018299.
Klepser, M., et al., International J. of Antimicrobial Agents, vol. 17, No. Supp 1, Jun. 2001, p. S157, 22nd International Congress of Chemotherapy; Amsterdam, Jun. 30-Jul. 3, 2001 XP002244592.
Bergogne-Berezin Eugenie, Pathologie Biologie, vol. 43, No. 6, 1995, pp. 498-504, “Azithromycin: Tissue pharmacokinetic data” XP008018308.
Law et al., The Annals of Pharmacotherapy, vol. 38, pp. 433-439, Mar., 2004, “Single-Dose Azithromycin for Respiratory Tract Infections”.
Arguedas, A., Single-Dose Therapy In Otitis Media, Poster Presentation at 9thEuropean Congress of Clinical Microbiology and Infectious Diseases, Berlin, Germany, Mar. 21-24, 1999, Clin. Microbiol. Infect. 1999:5 (Supp. 3 Mar.):28 (Abstr).
P/S/L Consulting Group Inc., Single-Dose Zithromax (Azithromycin) as Effective as 10 Days of Augmentin (Amoxcillin/Clavulenate) for Otitis Media, Doctor's Guide; Sep. 14, 2000.
FDA Briefing Package: Zithromax® (Azithromycin) Oral Suspension Single-Dose and Three Day Treatment of Acute Otitis Media, Anti-Infective Drugs Advisory Committee, Nov. 7, 2001.

Affiliated with

Also associated with

Rating

Single dose azithromycin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Single dose azithromycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single dose azithromycin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3646528